February 04, 2019
GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)
Media
February 01, 2019
BONESUPPORTTM and Lund University to present at Orthopaedic Research Society (ORS) 2019 Annual Meeting
January 30, 2019
Q4 incl. Full Year Report 2018
January 29, 2019
Modus Therapeutics strengthens Board with two key appointments
January 29, 2019
Altimmune Announces Presentation of HepTcell Phase 1 Results at The International Liver Congress™ in Vienna, Austria
January 25, 2019
Nordic Nanovector – Private placement successfully completed
January 24, 2019
Nordic Nanovector ASA (OSE: NANO) nomination committee proposes new Chairman
January 24, 2019
Oncopeptides has completed a directed share issue of approximately SEK 546 million
January 17, 2019
Targovax granted European Patent for mutant-RAS neoantigen platform lead products
January 11, 2019
Actavis infringes Orexo’s long term Zubsolv® US patent ´330